Ovarian cancer laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) No edit summary |
Hudakarman (talk | contribs) Lab |
||
| Line 16: | Line 16: | ||
** OVA1 | ** OVA1 | ||
*Serum biomarkers of the germ cell and sex cord-stromal ovarian cancer: | *Serum biomarkers of the germ cell and sex cord-stromal ovarian cancer: | ||
**AFP | **AFP: alpha-fetoprotein | ||
**hCG | **hCG: human chorionic gonadotropin | ||
**LDH | **LDH: lactate dehydrogenase | ||
**E2 | **E2: estradiol | ||
**Inhibin | **Inhibin | ||
**Testost | **Testost: testosterone | ||
**DHEA | **Andro: androstenedione | ||
**AMH | **DHEA: dehydroepiandrostenedione | ||
**AMH: anti-Müllerian hormone | |||
Revision as of 16:31, 10 July 2019
|
Ovarian cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ovarian cancer laboratory findings On the Web |
|
American Roentgen Ray Society Images of Ovarian cancer laboratory findings |
|
Risk calculators and risk factors for Ovarian cancer laboratory findings |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
- Patients with ovarian cancer can present acutely or sub-acutely
- If there is clinical suspicion of malignancy, the evaluation includes laboratory work, imaging and surgical exploration for the definite diagnosis
- Routine lab work
- CBC
- CBP
- Serum biomarkers:
- CA 125
- Postmenopausal woman: should be measured
- Premenopausal woman: should be measured only if US shows highly suspicious malignant mass
- OVA1
- CA 125
- Serum biomarkers of the germ cell and sex cord-stromal ovarian cancer:
- AFP: alpha-fetoprotein
- hCG: human chorionic gonadotropin
- LDH: lactate dehydrogenase
- E2: estradiol
- Inhibin
- Testost: testosterone
- Andro: androstenedione
- DHEA: dehydroepiandrostenedione
- AMH: anti-Müllerian hormone